Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-010738
Filing Date
2018-05-03
Accepted
2018-05-03 17:01:10
Documents
57
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 GTHX Q1 2018 10-Q gthx-10q_20180331.htm 10-Q 892802
2 EX-31.1 gthx-ex311_10.htm EX-31.1 15849
3 EX-31.2 gthx-ex312_8.htm EX-31.2 15580
4 EX-32.1 gthx-ex321_6.htm EX-32.1 7300
5 EX-32.2 gthx-ex322_7.htm EX-32.2 7334
6 GRAPHIC g2018050215395802723490.jpg GRAPHIC 1211
7 GRAPHIC g2018050215395803723492.jpg GRAPHIC 1219
8 GRAPHIC g2018050215395803423491.jpg GRAPHIC 1219
  Complete submission text file 0001564590-18-010738.txt   3609148

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT gthx-20180331.xml EX-101.INS 790288
10 XBRL TAXONOMY EXTENSION SCHEMA gthx-20180331.xsd EX-101.SCH 31946
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gthx-20180331_cal.xml EX-101.CAL 24320
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gthx-20180331_def.xml EX-101.DEF 71470
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE gthx-20180331_lab.xml EX-101.LAB 227045
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gthx-20180331_pre.xml EX-101.PRE 170466
Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Filer) CIK: 0001560241 (see all company filings)

EIN.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38096 | Film No.: 18804749
SIC: 2834 Pharmaceutical Preparations